DN1406131
- Generic Name
- DN1406131
Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Healthy Volunteers
- First Posted Date
- 2018-08-22
- Last Posted Date
- 2019-08-01
- Lead Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Target Recruit Count
- 56
- Registration Number
- NCT03641794
- Locations
- 🇨🇳
PKUCare Luzhong Hospital, Zibo, Shandong, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath